We are live on ! Find out more
HARP

Harpoon Therapeutics, Inc. Common Stock
HARP

Delisted

HARP was delisted on the 8th of March, 2024.

Back to rankings

79 hedge funds and large institutions have $341M invested in Harpoon Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

14% more funds holding

Funds holding: 69 → 79 (+10)

14% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 21

2% more capital invested

Capital invested by funds: $335M → $341M (+$5.62M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

27% less call options, than puts

Call options by funds: $762K | Put options by funds: $1.05M

Holders
79
Holders Change
+10
Holders Change %
+14.49%
% of All Funds
1.59%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
18
Increased
24
Reduced
21
Closed
8
Calls
$762K
Puts
$1.05M
Net Calls
-$287K
Net Calls Change
-$287K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.45M
2
BlackRock
BlackRock
New York
+$1.92M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.58M
4
TCM
Tekla Capital Management
Massachusetts
+$1.53M
5
PAM
Panagora Asset Management
Massachusetts
+$759K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$14M
2
Millennium Management
Millennium Management
New York
-$3.31M
3
AG
Artal Group
Luxembourg
-$1.44M
4
N
Nuveen
North Carolina
-$1.3M
5
CAM
Cormorant Asset Management
Massachusetts
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$608K +$182K +1,263 +54%
Goldman Sachs
27
Goldman Sachs
New York
$560K -$327K -2,265 -41%
GCP
28
GSA Capital Partners
United Kingdom
$548K +$298K +2,069 +179%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$532K +$145K +1,002 +47%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$527K -$2.45K -17 -0.5%
Two Sigma Investments
31
Two Sigma Investments
New York
$489K -$3.17K -22 -0.8%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$476K +$404K +2,800 New
Wells Fargo
33
Wells Fargo
California
$427K +$6.63K +46 +2%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$419K +$17.3K +120 +5%
RJA
35
Raymond James & Associates
Florida
$392K +$333K +2,308 New
MAM
36
Martingale Asset Management
Massachusetts
$391K -$459K -3,180 -58%
Verition Fund Management
37
Verition Fund Management
Connecticut
$382K +$325K +2,250 New
AQR Capital Management
38
AQR Capital Management
Connecticut
$381K +$324K +2,244 New
Man Group
39
Man Group
United Kingdom
$342K +$290K +2,013 New
Acadian Asset Management
40
Acadian Asset Management
Massachusetts
$334K -$41.8K -290 -13%
AllianceBernstein
41
AllianceBernstein
Tennessee
$306K +$20.2K +140 +8%
Los Angeles Capital Management
42
Los Angeles Capital Management
California
$304K +$68.2K +473 +36%
VEA
43
Virtus ETF Advisers
New York
$297K -$34.3K -238 -12%
Squarepoint
44
Squarepoint
New York
$294K -$307K -2,131 -55%
BRA
45
Blue Rock Advisors
Minnesota
$286K +$242K +1,679 New
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$276K +$235K +1,626 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$271K – – –
Barclays
48
Barclays
United Kingdom
$252K -$119K -828 -36%
T. Rowe Price Associates
49
T. Rowe Price Associates
Maryland
$237K +$201K +1,396 New
WS
50
Wedbush Securities
California
$235K +$199K +1,382 New
1
2
3 4

HARP Hedge Fund Activity: Q3 2020 in Review

79 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q3 2020, worth a combined $341M — up 1.7% from $335M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new HARP positions and 8 closed out — a net gain of 10 holders — while 24 added to existing stakes and 21 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $7.45M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $14M sold.

  • 79 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q3 2020, up from 69 in Q2 2020.
  • Funds reported $341M of Harpoon Therapeutics, Inc. Common Stock stock for Q3 2020, up 1.7% quarter-over-quarter.
  • 18 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q3 2020 and 8 closed out, a net change of +10 holders.
  • The largest Harpoon Therapeutics, Inc. Common Stock buyer in Q3 2020 was Point72 Asset Management, an estimated $7.45M added.
  • The largest Harpoon Therapeutics, Inc. Common Stock seller in Q3 2020 was Consonance Capital Management, an estimated $14M sold.

Based on aggregated 13F filings for Q3 2020.